Mayo Clinic-accelerated AI company completes seed round

AccurKardia, a medical software company using artificial intelligence that the Mayo Clinic selected for its accelerator program, raised $2.7 million in seed funding.

Advertisement

The company was selected to join Rochester, Minn.-based health system’s third cohort of the Platform_Accelerate program. Through the partnership, AccurKardia gained access to Mayo Clinic’s data sets, validation frameworks, clinical workflow planning and mentorship, according to a June 20 AccurKardia news release.

The company focused on delivering the interpretation of electrocardiograms.

“With advances in AI, edge computing capabilities, and ubiquitous connectivity, a perfect storm is brewing to deliver planetary-scale tech-enabled healthcare. Our team is primed to develop groundbreaking, life-changing software to interact with clinical and consumer wearables,” Sadeq Ali, co-founder, chief people officer and chief technology officer of AccurKardia, said in the release.

Becker’s 3rd Annual Fall Chief Pharmacy Officer Summit is the top tier event that the people leading the future of pharmacy convene. This 3-day event is built specifically for Chief Pharmacy Officers and senior pharmacy leaders. The sessions examine the workforce, financial and clinical priorities shaping pharmacy today. Becker’s is where candid discussions flourish and new ideas thrive. Becker's 3rd Annual Fall Chief Pharmacy Officer Summit

Advertisement

Next Up in Innovation

Advertisement

Comments are closed.